BONELLI, Mara
 Distribuzione geografica
Continente #
EU - Europa 284
AS - Asia 115
NA - Nord America 113
AF - Africa 5
OC - Oceania 4
SA - Sud America 2
Totale 523
Nazione #
IT - Italia 130
US - Stati Uniti d'America 107
IE - Irlanda 50
CN - Cina 35
DE - Germania 28
FR - Francia 28
IN - India 19
JP - Giappone 14
KR - Corea 14
GB - Regno Unito 9
TW - Taiwan 9
NL - Olanda 7
VN - Vietnam 6
CA - Canada 5
MY - Malesia 5
AU - Australia 4
FI - Finlandia 4
RU - Federazione Russa 4
SE - Svezia 4
UA - Ucraina 4
BE - Belgio 3
EG - Egitto 3
CH - Svizzera 2
DZ - Algeria 2
ES - Italia 2
HU - Ungheria 2
ID - Indonesia 2
KZ - Kazakistan 2
SG - Singapore 2
TH - Thailandia 2
TR - Turchia 2
AT - Austria 1
BO - Bolivia 1
BR - Brasile 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
HK - Hong Kong 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
NO - Norvegia 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
Totale 523
Città #
Dublin 49
Parma 42
Arezzo 16
Ann Arbor 12
Boardman 12
Ashburn 10
Shanghai 10
Hangzhou 9
Medolla 8
Milan 7
Yongsan 7
Mcallen 6
Suita 6
Casarano 5
Naples 5
Rome 5
Bremen 4
Dong Ket 4
Guangzhou 4
Helsinki 4
Indianapolis 4
Los Angeles 4
Xian 4
Beijing 3
Council Bluffs 3
Detroit 3
Footscray 3
Gent 3
Houston 3
Leonia 3
Paris 3
Taipei 3
Washington 3
Waterville 3
Amstelveen 2
Bangalore 2
Carate Brianza 2
Casina 2
Concord 2
Danbury 2
Delhi 2
Gladbeck 2
Gold 2
Hyderabad 2
Jijelli 2
London 2
Madrid 2
Pavia 2
Pittsburgh 2
Pune 2
Sant'ilario D'enza 2
Seoul 2
Serra 2
Slough 2
Szeged 2
Tokyo 2
Toronto 2
Vadodara 2
Weston-super-mare 2
Aktobe 1
Amagasaki 1
Ancona 1
Atlanta 1
Bacoli 1
Baltimore 1
Bengaluru 1
Bhavnagar 1
Bologna 1
Borås 1
Boston 1
Bromma 1
Brooklyn 1
Cagliari 1
Caledon 1
Casalgrande 1
Chandigarh 1
Chengdu 1
Cincinnati 1
Cochabamba 1
Dallas 1
East Syracuse 1
Edmonton 1
Fayetteville 1
Ferrara 1
Frederick 1
Gainesville 1
Garching 1
Genoa 1
Genova 1
Hanoi 1
Harada 1
Islamabad 1
Izmir 1
Kansas City 1
Konstanz 1
Kyoto 1
Lake Forest 1
Lexington 1
Manipal 1
Memphis 1
Totale 361
Nome #
Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer, file e177fbc4-42b8-50b0-e053-d805fe0adaee 120
Efficacy of the cdk4/6 dual inhibitor abemaciclib in egfr-mutated nsclc cell lines with different resistance mechanisms to osimertinib, file e177fbc7-275c-50b0-e053-d805fe0adaee 42
New therapeutic strategies for malignant pleural mesothelioma, file e177fbc7-6d9a-50b0-e053-d805fe0adaee 35
Pemetrexed enhances membrane PD-L1 expression and potentiates T cell-mediated cytotoxicity by anti-PD-L1 antibody therapy in non-small-cell lung cancer, file e177fbc6-c828-50b0-e053-d805fe0adaee 32
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells., file e177fbc5-d274-50b0-e053-d805fe0adaee 29
null, file e177fbc4-3a65-50b0-e053-d805fe0adaee 28
Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer, file e177fbc4-374a-50b0-e053-d805fe0adaee 26
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines, file e177fbc5-e007-50b0-e053-d805fe0adaee 21
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines, file e177fbc4-3e0a-50b0-e053-d805fe0adaee 18
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC, file e177fbc6-8be1-50b0-e053-d805fe0adaee 18
Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells, file e177fbc6-9bb6-50b0-e053-d805fe0adaee 16
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines, file e177fbc5-2589-50b0-e053-d805fe0adaee 15
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines., file e177fbc6-8938-50b0-e053-d805fe0adaee 14
Heat-induced proteasomic degradation of HSF1 in serum-starved human fibroblasts aging in vitro, file e177fbc4-2222-50b0-e053-d805fe0adaee 11
Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion, file e177fbc7-5975-50b0-e053-d805fe0adaee 11
Attenuated expression of 70kDa heat shock protein in WI-38 human fibroblasts during aging in vitro, file e177fbc4-0cb5-50b0-e053-d805fe0adaee 10
Osmotic regulation of ATA2 mRNA expression and amino acid transport system A activity, file e177fbc4-0d42-50b0-e053-d805fe0adaee 10
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation, file e177fbc7-5aef-50b0-e053-d805fe0adaee 9
New treatment opportunities in phosphatase and tensin homolo(PTen)-deficient tumors: Focus on PTen/focal adhesion kinase pathway, file e177fbc7-a9df-50b0-e053-d805fe0adaee 7
New therapeutic strategies for malignant pleural mesothelioma, file e177fbc5-6e69-50b0-e053-d805fe0adaee 6
Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation, file e177fbc7-1d2f-50b0-e053-d805fe0adaee 5
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells, file e177fbc7-4245-50b0-e053-d805fe0adaee 5
Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation, file e177fbc7-5af1-50b0-e053-d805fe0adaee 5
Stabilization of hsp70 mRNA on prolonged cell exposure to hypertonicity, file e177fbc4-0d41-50b0-e053-d805fe0adaee 4
Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones. (Cavazzoni and Bonelli co-first authors), file e177fbc4-2810-50b0-e053-d805fe0adaee 4
Compatible osmolytes modulate the response of porcine endothelial cells to hypertonicity and protect them from apoptosis, file e177fbc4-0cec-50b0-e053-d805fe0adaee 3
Synergistic activity of letrozole and sorafenib on breast cancer cells, file e177fbc4-1f38-50b0-e053-d805fe0adaee 3
Targeting PI3K somatic mutations reduces invasion and EMT in squamous cell carcinoma of the lung, file e177fbc4-8054-50b0-e053-d805fe0adaee 3
Functional characterization of gefitinib uptake in non-small cell lung cancer cell lines, file e177fbc4-1f39-50b0-e053-d805fe0adaee 2
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN, file e177fbc5-953c-50b0-e053-d805fe0adaee 2
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation, file e177fbc7-56f9-50b0-e053-d805fe0adaee 2
The effect of heat shock on amino acid transport and cell volume in 3T3 cells, file e177fbc4-0d43-50b0-e053-d805fe0adaee 1
Induction of BGT-1 and amino acid system A transport activities in endothelial cells exposed to hyperosmolarity, file e177fbc4-0d44-50b0-e053-d805fe0adaee 1
Increased level of inducible HSP70 in cells exposed to electromagnetic fields., file e177fbc4-0e60-50b0-e053-d805fe0adaee 1
Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification, file e177fbc4-3c48-50b0-e053-d805fe0adaee 1
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations., file e177fbc4-8faf-50b0-e053-d805fe0adaee 1
The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells, file e177fbc6-03ea-50b0-e053-d805fe0adaee 1
Dual inhibition of CDK4/6 and PI3K/AKT/mTOR signaling impairs energy metabolism in MPM cancer cells, file e177fbc7-a024-50b0-e053-d805fe0adaee 1
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFR, file e177fbc7-ab25-50b0-e053-d805fe0adaee 1
Totale 524
Categoria #
all - tutte 1.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.453


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 1 0 0 0 0 0 0 0 0 0 0
2020/202116 0 0 0 0 0 1 0 1 3 0 2 9
2021/202258 2 19 0 6 3 0 12 1 3 2 2 8
2022/2023152 8 1 2 5 10 4 7 12 76 2 17 8
2023/202470 7 3 5 10 0 3 19 10 4 9 0 0
Totale 524